Objective: The objective of this study was to assess health care professionals' knowledge of evidencebased guidelines for the nonsurgical treatment of obesity. Methods: A nationally representative sample of internists, family practitioners, obstetricians/gynecologists, and nurse practitioners completed a web-based survey between June 9 and July 1, 2016 (n 5 1,506). Results: Only 16% of respondents indicated that obesity counseling should be provided approximately twice monthly in an individual or group setting for at least 6 months, in accordance with United States Preventive Services Task Force and Centers for Medicare and Medicaid Services guidelines. Only 15% of respondents identified BMI ! 27 kg/m 2 with an obesity-associated comorbid condition as the appropriate indication to prescribe pharmacotherapy for patients. Two-thirds of respondents indicated that it is appropriate to continue long-term pharmacotherapy under conditions inconsistent with evidence-based guidelines, with nearly one-quarter indicating that obesity medications should never be prescribed beyond 3 months regardless of weight loss. Conclusions: These findings suggest that provider understanding of appropriate clinical care for obesity is inconsistent with evidence-based recommendations. As coverage for behavioral counseling services and pharmacotherapy expands, it is imperative that health care professionals understand how to effectively leverage these treatment modalities to optimize health outcomes for patients with obesity.
Introduction
Adults with obesity (BMI ! 30 kg/m 2 ) incur 42% higher medical costs per capita and are nearly two times more likely to die before age 70 than adults with a healthy weight (1, 2) . Health care providers (HCPs) play a vital role in the prevention, treatment, and control of obesity. Evidence suggests that multicomponent behavioral interventions (intensive behavioral therapy [IBT] ), pharmacotherapy, and bariatric surgery are all effective strategies that support clinically significant weight loss (!5% reduction in body weight) for persons with obesity (3, 4) . Yet application of these evidence-based treatments is uncommon (5, 6) . Rates of IBT actually declined slightly between 1995 and 2008, despite the steady rise in obesity prevalence during this period, and remain low at present (7, 8) .
A previous survey found that 97% of HCPs believed they were partly or solely responsible for ensuring that patients were counseled on obesity (9) . Persistently low rates of counseling are at odds with providers' self-proclaimed sense of responsibility for addressing obesity, suggesting that additional factors deter HCPs from addressing weight with their patients. HCPs have cited lack of time, limited reimbursement, and lack of training as major barriers that prevent them from addressing obesity with their patients (9) . When asked what would lead them to bring up obesity in conversation, 68% of HCPs indicated that an obesity-related risk factor would prompt discussion, while 57% indicated that they would wait for the patient to broach the topic.
Beyond behavioral counseling, recent data suggest that HCPs vary widely in their provision of pharmacotherapy and bariatric surgery for patients with obesity. In a survey of US providers, Petrin et al. (10) found that 31% of HCPs would not prescribe pharmacotherapy for obesity under any circumstances, with men and underweight providers more likely than women and providers at a healthy weight to indicate pharmacotherapy was an acceptable treatment modality. While 89% of HCPs were willing to refer patients for bariatric surgery, assuming no contraindications, less than one-third would refer at the guideline-recommended BMI threshold (BMI ! 40 or BMI ! 35 with a comorbid condition). Delayed or absent referrals impair access to evidence-based bariatric procedures, which may be the most effective treatment for patients with severe obesity who are not able to achieve or maintain substantial weight loss through nonsurgical interventions (11).
Although Petrin et al. (9, 10) provided information on obesity-related attitudes and treatment practices across provider types, the predictors of such attitudes and practices remain unclear. One possible explanation is that HCPs lack adequate knowledge of the current guidelines for clinical obesity management. Thus, we are making a critical distinction between attitudes (and beliefs) and knowledge levels. Whereas attitudes and beliefs about what constitutes appropriate obesity management are subjectively held constructs based in culture and norms, knowledge is a more objective measure of a provider's theoretical or practical understanding of the topic derived from didactic education. In this study, we assessed knowledge of nonsurgical obesity treatment guidelines among family practitioners (FPs), internists, obstetricians/gynecologists (OB-GYNs), and nurse practitioners (NPs) (3, 4, 12) .
Methods
Data were collected in June 2016 using DocStyles, a web-based survey administered to a panel of 1,506 verified HCPs. In concert with Porter Novelli, a public relations firm specializing in health and social marketing, we designed obesity-specific questions for inclusion in the survey. The national sample used for analysis was randomly drawn from SER-MO'S Global Medical Panel, which includes more than 330,000 medical professionals in the United States. The sample included 1,003 primary care physicians (480 FPs and 523 internists), 250 OB-GYNs, and 253 NPs. Participants were screened to include only those who practice in the United States, actively see adult patients, and have been practicing for at least 3 years. HCPs serving only pediatric patients were The full DocStyles panel contained 144 questions designed to provide insight into HCPs' attitudes and counseling behaviors on a variety of health issues. The present analysis examined responses to five questions designed to assess participants' understanding of obesity treatment guidelines in the context of various HCP characteristics (gender, race, age, height, weight, type and practice setting, average income of patients served, and years in practice). Self-reported height and weight data were used to calculate each respondent's BMI. Participants were asked questions to assess their knowledge of guidelines regarding the recommended minimum level of physical activity, the recommended duration and intensity of weight loss counseling, appropriate eating patterns for weight loss, the appropriate threshold to prescribe weight loss medications, and when it is appropriate to prescribe weight loss medications long term (Table  T1 1). v 2 tests, odds ratios (OR), and generalized linear models were used to assess differences in provider responses by specialty, BMI, gender, years in practice, and typical household income of patients seen.
Results
The overall response rate for the survey was 64.5%. Table 1 summarizes respondent demographic characteristics. After controlling for demographic variables (e.g., age, patient volume, practice setting), HCP knowledge of clinical guidelines for physical activity, behavioral counseling, and pharmacotherapy varied significantly by provider type and years in practice (Table  T2 2). Overall, HCPs were most knowledgeable of the physical activity guidelines (49% correct). HCPs were least likely to identify evidence-based guidelines when selecting the recommended intensity of obesity counseling (15% correct).
Only two providers (0.1%) selected responses consistent with evidence-based recommendations from all five guidelines assessed by the survey. Most participants (84%) failed to identify practices consistent with evidence-based obesity treatment guidelines for the majority of questions (!3 incorrect). The average number of guideline-aligned responses varied significantly by provider type and was highest among FPs (M 5 1.65, 95% CI: 1.53-1.77) and lowest among internists (M 5 1.40, 95% CI: 1.28-1.51) after controlling for years in practice. FPs were significantly more likely than internists, NPs, and OB-GYNs to identify the correct guidelines for obesity counseling and pharmacotherapy ( Figure  F1  1 ).
Eating patterns for weight loss
Overall, 33% of HCPs correctly identified the NHLBI guideline that indicates any eating pattern suitable for the patient can be 
According to NHLBI guidelines, which of the eating patterns for weight loss is recommended for patients with overweight or obesity? 
Intensive behavioral therapy
Fewer than 20% of providers recommended the counseling option consistent with United States Preventive Services Task Force guidelines (3). FPs (19%) and NPs (17%) were most likely to identify the correct counseling guideline. Among respondents who selected incorrectly, NPs were significantly more likely than FPs to select options that specified counseling provided by a dietician (OR 5 2.08, 95% CI: 1.54-2.86) (Supporting Information Table S1 ). Collectively, physicians (14%) were significantly more likely than NPs (5%) to indicate that no counseling option is recommended for patients with obesity (OR 5 3.06, 95% CI: 1.71-5.46). Responses varied significantly by years in practice and patient volume ( Figure  F2 2).
Physical activity
About half (49%) of providers correctly identified that 150 minutes of moderate-intensity physical activity per week is the guidelinerecommended minimum level of physical activity to achieve substantial health benefits (13) . NPs (53%) and FPs (52%) were most likely to identify the correct guideline, but responses did not vary significantly by provider type. Of providers identifying an incorrect guideline, 25% selected a level of physical activity higher than the recommended minimum (e.g., longer duration, higher intensity), and 20% selected a level lower than the recommended minimum (e.g. shorter duration).
Pharmacotherapy for obesity
Only 8% of HCPs correctly identified the guideline-recommended thresholds to initiate and continue pharmacotherapy for obesity (Figure  F3  3 ) (12) . Seventy-seven percent of HCPs selected a prescribing threshold higher than recommended for patients with an obesityassociated comorbidity, and 26% indicated long-term pharmacotherapy only for patients achieving at least 10% to 15% reduction in body weight. FPs (19%) and internists (16%) were significantly more likely than NPs and OB-GYNs to identify prescribing practices consistent with evidence-based guidelines (OR 5 2.25, 95% CI: 1.59-3.19). While only 4% of HCPs in this study indicated that obesity medications should never be prescribed, one in five respondents indicated that long-term pharmacotherapy is unsafe.
Discussion
This study is the first from a large, randomly selected sample of active HCPs to confirm that 1) HCP knowledge of physical activity and dietary guidelines is limited and 2) HCP understanding of the appropriate initiation, intensity, and duration for provision of IBT and pharmacotherapy is often inconsistent with evidence-based guidelines. These results complement findings from previous analyses of HCP self-reported behaviors (5, 14) , particularly prescribing behavior for obesity pharmacotherapy (Table  T3  3 ). Our findings indicate that significant gaps in HCP knowledge of evidence-based guidelines for obesity management may underlie low rates (15) of IBT and pharmacotherapy for patients with obesity.
Unlike previous surveys (5,7,9,10,16,17), the questions used in this analysis were designed to assess HCP knowledge of various evidence-based obesity treatment guidelines rather than their attitudes or behaviors. Because knowledge of obesity management is not routinely assessed by medical licensing exams (18) , this analysis provides unique information on where knowledge is most lacking and how understanding of IBT and pharmacotherapy guidelines differs for FPs, internists, OB-GYNs, and NPs. As an assessment of current HCP knowledge, our findings fill an important evidence gap in recent efforts to explain why widespread provider beliefs about the importance of addressing obesity (9) seldom translate into provision of evidence-based treatments in clinical practice (10) .
Differences in baseline training in obesity management and postgraduate clinical experiences may account for some of the observed variation in knowledge across provider groups. Unfortunately, comparable national data on profession-and specialty-specific training requirements for obesity management are scarce (6, 19) . The greater Question fielded on 2015 DocStyles survey [10] ; totals exclude HCPs indicating that they do not prescribe drug therapy for obesity. b Responses from family practitioners and internists (PCPs) are grouped for comparability to 2015 analysis in which they were combined.
c Indicates guideline-recommended BMI threshold for pharmacotherapy [12] . OB-GYNs, obstetricians/gynecologists; NPs, nurse practitioners; PCP, primary care physician.
knowledge of obesity treatment guidelines demonstrated by FPs relative to internists and OB-GYNs in this analysis aligns well with a recent study of Ohio residency programs that found FPs received significantly more hours of didactic training related to obesity, physical activity, and nutrition than internists or OB-GYNs (20) . Supporting the link between poor understanding of evidence-based guidelines and clinical practice, a national review of patient encounters found that OB-GYNs were the main source of preventive care for more than onethird of nonpregnant women, but they were less likely than FPs to provide obesity counseling (21) and seldom prescribed pharmacotherapy (22) . Similarly low rates of pharmacotherapy were reported by NPs (9), although this is partly explained by inconsistent scope of practice laws governing prescriptive authority at the state level.
Importantly, previous DocStyles analyses have found that both OBGYNs and NPs were significantly more likely than FPs and internists to indicate that additional training in obesity management would improve their ability to counsel patients with obesity (9, 10) . Although results from the present analysis suggest that all provider types will benefit from enhanced graduate and postgraduate learning opportunities in obesity management, the additional training may be particularly well received by OB-GYNs and NPs, who are increasingly called upon to deliver comprehensive primary care services for US adults. Furthermore, system-wide changes in education and reimbursement policy over the past several decades may explain some of the within-group response variation observed by years in practice. For example, the recent expansion of Medicare reimbursement for IBT (23) may partly explain why providers who entered practice within the past 10 years were more likely to recommend the IBT option consistent with Centers for Medicare and Medicaid Services guidelines.
It is also possible that individual differences in weight bias contributed to the substantial within-group response variation in this analysis. Weight bias can be both a mediator and product of inadequate knowledge and training on obesity (24), making its effects particularly difficult to parse (25) . Our finding that one-third of HCPs would delay pharmacotherapy until BMI ! 35, even in the presence of a comorbid condition, might be evidence that many HCPs still perceive obesity as a disease of willpower that can be ameliorated simply by eating less and exercising more-an antiquated mantra rooted in weight bias. Yet HCPs who recommended initiation of pharmacotherapy at BMI ! 35 were also four times more likely than HCPs who recommended initiation at BMI ! 27 to indicate that FDA-approved medications for obesity are unsafe for long-term use. Together, these findings suggest that weight bias and misinformation about the safety and efficacy of obesity medications approved for longterm use may work synergistically to deter HCPs from utilizing effective pharmacotherapies in accordance with evidence-based guidelines (12) .
Limitations
Although this analysis includes responses from a large, nationally representative sample of active US HCPs, it has several limitations. The survey did not capture responses from several important provider types, including physician assistants, and the findings may not be generalizable to all US HCPs. Although participants were randomly selected, inclusion in the SERMO medical panel from which participants were drawn is inherently prone to selection bias. Based on unpublished demographic data from previously conducted surveys, it is also possible that a small number of respondents included in this analysis had prior specialty training in obesity management. While we did not assess the number or distribution of obesity specialists across HCP groups, a concentration of obesity specialists within subsamples could explain some of the intergroup variation in responses. Furthermore, the DocStyles survey instrument has not been formally tested for reliability or validity. Any psychometric assessment is subject to nonsampling errors, including specification error, measurement error, and random response error. Although questions and answer choices were designed to minimize response bias, we did not control for differential interpretations of questions or other sources of error that may have influenced responses. Thus, it is possible that the results do not accurately reflect knowledge of obesity treatment guidelines for some respondents.
Implications
Our findings offer insight on HCPs' familiarity with the clinical guidelines for provision of evidence-based obesity treatment modalities, but the survey did not directly assess the effect of provider knowledge on provision of counseling and pharmacotherapy services. Assuming HCPs provide treatment according to their knowledge of evidencebased guidelines, our data suggest that HCPs are waiting too long to initiate treatment and maintaining unrealistic outcome expectations for initial weight loss when they do. Additional research is needed to clarify the extent to which improving HCP knowledge of clinical guidelines for obesity management will improve quality of care and population health outcomes. Furthermore, the impact of pervasive weight stigma on HCP understanding of ideal approaches to obesity management should not be discounted when considering systematic drivers of suboptimal or absent obesity care.
Implementation of the recently released HCP competencies for the prevention and treatment of obesity (26) , tools to facilitate improved clinical decision-making, and standardized reimbursement policies could bolster HCPs' self-efficacy and increase provision of effective services that improve health outcomes for patients with obesity (27) . Given the multitude of distinct but overlapping obesity management guidelines currently in existence (4, 12, 28) , synthesis of a practical, unified standard of care may help knowledgeable HCPs to successfully implement evidence-based obesity care in a variety of settings.
Conclusion
These findings indicate that HCP understanding of appropriate clinical care for obesity is inconsistent with evidence-based recommendations. Our data suggest that limited understanding of when and how to deliver evidence-based treatments likely deters HCPs from addressing obesity with their patients. As coverage for behavioral counseling services and pharmacotherapy expands, it is imperative that health professional training programs better prepare HCPs to leverage evidence-based treatment modalities that can optimize health outcomes for patients with obesity.O V C 2018 The Obesity Society
